Intellectual Property India Publishes Patent Application for Neurosync-Schizophrenia Treatment Adherence & Relapse Prevention System

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202641099958 A) filed by Saveetha Institute Of Medical And Technical Sciences on August 19, 2026, for Neurosync-Schizophrenia Treatment Adherence & Relapse Prevention System.

Inventors include Sai Saranya Narra; Dr Sathish Kumar; and Dr Ramya Mohan.

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: In response to the increasing need for continuous and reliable mental-health care, particularly for schizophrenia treatment, this project introduces NeuroSync, an AI- powered Schizophrenia Treatment Adherence and Relapse Prevention System. NeuroSync is designed as a structured, caregiver-driven digital...